These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24762166)

  • 21. Fixed versus variable dose of prothrombin complex concentrate for counteracting vitamin K antagonist therapy.
    Khorsand N; Veeger NJ; Muller M; Overdiek JW; Huisman W; van Hest RM; Meijer K
    Transfus Med; 2011 Apr; 21(2):116-23. PubMed ID: 21073580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of intracranial bleeding managed with prothrombin complex concentrate in patients on direct factor Xa inhibitors or vitamin K antagonists.
    Bavalia R; Abdoellakhan R; Beenen LF; Brekelmans MPA; Olie RH; Ten Cate H; Huisman MV; Kruip M; Middeldorp S; Meijer K; Hutten BA; Coppens M
    Thromb Res; 2020 Dec; 196():404-409. PubMed ID: 33011638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fixed Versus Variable Dosing of Prothrombin Complex Concentrate for Bleeding Complications of Vitamin K Antagonists-The PROPER3 Randomized Clinical Trial.
    Abdoellakhan RA; Khorsand N; Ter Avest E; Lameijer H; Faber LM; Ypma PF; Nieuwenhuizen L; Veeger NJGM; Meijer K
    Ann Emerg Med; 2022 Jan; 79(1):20-30. PubMed ID: 34535300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding.
    Schick KS; Fertmann JM; Jauch KW; Hoffmann JN
    Crit Care; 2009; 13(6):R191. PubMed ID: 19948037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and effectiveness of a prothrombin complex concentrate in approved and off-label indications.
    Marcos-Jubilar M; García Erce JA; Martínez-Calle N; Páramo JA; Martínez Virto A; Quintana-Díaz M
    Transfus Med; 2019 Aug; 29(4):268-274. PubMed ID: 31347218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial.
    Goldstein JN; Refaai MA; Milling TJ; Lewis B; Goldberg-Alberts R; Hug BA; Sarode R
    Lancet; 2015 May; 385(9982):2077-87. PubMed ID: 25728933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
    Yasaka M; Sakata T; Naritomi H; Minematsu K
    Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid warfarin reversal: a 3-factor prothrombin complex concentrate and recombinant factor VIIa cocktail for intracerebral hemorrhage.
    Sarode R; Matevosyan K; Bhagat R; Rutherford C; Madden C; Beshay JE
    J Neurosurg; 2012 Mar; 116(3):491-7. PubMed ID: 22175718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prothrombin complex concentrate for vitamin K antagonist reversal in acute bleeding settings: efficacy and safety.
    Ostermann H; von Heymann C
    Expert Rev Hematol; 2019 Jul; 12(7):525-540. PubMed ID: 31159607
    [No Abstract]   [Full Text] [Related]  

  • 30. Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication.
    Yasaka M; Sakata T; Minematsu K; Naritomi H
    Thromb Res; 2002 Oct; 108(1):25-30. PubMed ID: 12586128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased risk of volume overload with plasma compared with four-factor prothrombin complex concentrate for urgent vitamin K antagonist reversal.
    Refaai MA; Goldstein JN; Lee ML; Durn BL; Milling TJ; Sarode R
    Transfusion; 2015 Nov; 55(11):2722-9. PubMed ID: 26135740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective evaluation of the clinical use of prothrombin complex concentrate for the reversal of anticoagulation with vitamin K antagonists.
    Cruz JL; Moss MC; Chen SL; Hansen KM; Amerine LB
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):378-82. PubMed ID: 25688457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An observational, prospective, two-cohort comparison of a fixed versus variable dosing strategy of prothrombin complex concentrate to counteract vitamin K antagonists in 240 bleeding emergencies.
    Khorsand N; Veeger NJ; van Hest RM; Ypma PF; Heidt J; Meijer K
    Haematologica; 2012 Oct; 97(10):1501-6. PubMed ID: 22491734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prothrombin complex concentrate administration for bleeding associated with non-vitamin K antagonist oral anticoagulants: The SAMURAI-NVAF study.
    Yoshimura S; Sato S; Todo K; Okada Y; Furui E; Matsuki T; Yamagami H; Koga M; Takahashi JC; Nagatsuka K; Arihiro S; Toyoda K;
    J Neurol Sci; 2017 Apr; 375():150-157. PubMed ID: 28320118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticoagulation Reversal Strategies for Left Ventricular Assist Device Patients Presenting with Acute Intracranial Hemorrhage.
    Wong JK; Chen PC; Falvey J; Melvin AL; Lidder AK; Lowenstein LM; Miranpuri AS; Knight PA; Massey HT
    ASAIO J; 2016; 62(5):552-7. PubMed ID: 27347708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse Events Following International Normalized Ratio Reversal in Intracerebral Hemorrhage.
    Laible M; Jenetzky E; Beynon C; Müller OJ; Sander P; Schüler S; Purrucker J; Möhlenbruch M; Steiner T; Veltkamp R; Ringleb PA; Rizos T
    Cerebrovasc Dis; 2016; 42(5-6):446-454. PubMed ID: 27536779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal strategies for vitamin K antagonists in acute intracerebral hemorrhage.
    Parry-Jones AR; Di Napoli M; Goldstein JN; Schreuder FH; Tetri S; Tatlisumak T; Yan B; van Nieuwenhuizen KM; Dequatre-Ponchelle N; Lee-Archer M; Horstmann S; Wilson D; Pomero F; Masotti L; Lerpiniere C; Godoy DA; Cohen AS; Houben R; Al-Shahi Salman R; Pennati P; Fenoglio L; Werring D; Veltkamp R; Wood E; Dewey HM; Cordonnier C; Klijn CJ; Meligeni F; Davis SM; Huhtakangas J; Staals J; Rosand J; Meretoja A
    Ann Neurol; 2015 Jul; 78(1):54-62. PubMed ID: 25857223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of prothrombin complex concentrate administration and hematoma enlargement in non-vitamin K antagonist oral anticoagulant-related intracerebral hemorrhage.
    Gerner ST; Kuramatsu JB; Sembill JA; Sprügel MI; Endres M; Haeusler KG; Vajkoczy P; Ringleb PA; Purrucker J; Rizos T; Erbguth F; Schellinger PD; Fink GR; Stetefeld H; Schneider H; Neugebauer H; Röther J; Claßen J; Michalski D; Dörfler A; Schwab S; Huttner HB;
    Ann Neurol; 2018 Jan; 83(1):186-196. PubMed ID: 29314216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protocolized use of Factor Eight Inhibitor Bypassing Activity (FEIBA) for the reversal of warfarin induced coagulopathy.
    Htet NN; Barounis D; Knight C; Umunna BP; Hormese M; Lovell E
    Am J Emerg Med; 2020 Mar; 38(3):539-544. PubMed ID: 31176578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interhospital Transfer Delays Anticoagulation Reversal in Warfarin-Associated Intracranial Hemorrhage.
    Zepeski A; Rewitzer S; Leira EC; Harland K; Faine BA
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3345-3349. PubMed ID: 30172677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.